|
|
|
|
| LEADER |
00000nab a2200000 a 4500 |
| 001 |
vtls008875308 |
| 003 |
SK-MaSNL |
| 005 |
20260304030527.0 |
| 008 |
040806c2005 xo 0 slo |
| 015 |
|
|
|a SNBCL2005/5
|
| 035 |
|
|
|a SLK036428
|
| 040 |
|
|
|a SLKCL
|b slo
|c SNKBUCL
|e AACR2
|
| 041 |
1 |
|
|a slo
|b eng
|b slo
|
| 044 |
|
|
|a xo
|c SK
|
| 080 |
|
|
|a 616.62-006.6-07-08
|2 1981
|
| 100 |
1 |
|
|a Horňák, Michal,
|d 1929-2016
|4 aut
|9 25820
|
| 245 |
1 |
0 |
|a Primárny T1G3 karcinóm močového mechúra: nádor s vysokým rizikom progresie
|c Michal Horňák, Štefan Galbavý, Augustín Bárdoš
|
| 246 |
1 |
0 |
|a Primary T1G3 bladder carcinoma: tumour with high risk of progression
|
| 246 |
1 |
1 |
|a Primary T1G3 bladder carcinoma: tumour with high risk of progression
|
| 300 |
|
|
|b Obr.
|
| 504 |
|
|
|a Res. angl., slov.
|
| 504 |
|
|
|a Bibliogr. odkazy
|
| 650 |
0 |
7 |
|a nádory močového mechúra
|2 MESH
|9 20101
|
| 650 |
0 |
7 |
|a karcinóm papilárny
|x diagnostika
|2 MESH
|9 1308942
|
| 650 |
0 |
7 |
|a prognózy
|2 MESH
|9 3871
|
| 650 |
0 |
7 |
|a cystektómia
|2 MESH
|9 18209
|
| 650 |
0 |
7 |
|a farmakoterapia
|2 MESH
|9 14158
|
| 650 |
0 |
7 |
|a imunoterapia
|2 MESH
|9 14283
|
| 650 |
0 |
7 |
|a patológia
|2 MESH
|9 900
|
| 700 |
1 |
|
|a Galbavý, Štefan,
|d 1946-
|4 aut
|9 193632
|
| 700 |
1 |
|
|a Bárdoš, Augustín,
|d 1950-2016
|4 aut
|9 201350
|
| 773 |
0 |
|
|w SERIAL_GENERAL*000250*2005*005*004
|x 1335-3071
|t Urológia
|g Roč. 11, č. 4 (2005), s. 15-19
|
| 850 |
|
|
|a Slovenská lekárska knižnica v Bratislave
|a BA006
|
| 852 |
|
|
|a BA006
|b KIS3GCP
|b 000500000
|
| 999 |
|
|
|c 2634473
|d 2636403
|
